FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078347978> ?p ?o ?g. }

• W2078347978 endingPage "e0116841" @default.
• W2078347978 startingPage "e0116841" @default.
• W2078347978 abstract "The protein α-synuclein (α-Syn) has a central role in the pathogenesis of Parkinson’s disease (PD) and immunotherapeutic approaches targeting this molecule have shown promising results. In this study, novel antibodies were generated against specific peptides from full length human α-Syn and evaluated for effectiveness in ameliorating α-Syn-induced cell death and behavioral deficits in an AAV-α-Syn expressing rat model of PD. Fisher 344 rats were injected with rAAV vector into the right substantia nigra (SN), while control rats received an AAV vector expressing green fluorescent protein (GFP). Beginning one week after injection of the AAV-α-Syn vectors, rats were treated intraperitoneally with either control IgG or antibodies against the N-terminal (AB1), or central region (AB2) of α-Syn. An unbiased stereological estimation of TH+, NeuN+, and OX6 (MHC-II) immunostaining revealed that the α-Syn peptide antibodies (AB1 and AB2) significantly inhibited α-Syn-induced dopaminergic cell (DA) and NeuN+ cell loss (one-way ANOVA (F (3, 30) = 5.8, p = 0.002 and (F (3, 29) = 7.92, p = 0.002 respectively), as well as decreasing the number of activated microglia in the ipsilateral SN (one-way ANOVA F = 14.09; p = 0.0003). Antibody treated animals also had lower levels of α-Syn in the ipsilateral SN (one-way ANOVA F (7, 37) = 9.786; p = 0.0001) and demonstrated a partial intermediate improvement of the behavioral deficits. Our data suggest that, in particular, an α-Syn peptide antibody against the N-terminal region of the protein can protect against DA neuron loss and, to some extent behavioral deficits. As such, these results may be a potential therapeutic strategy for halting the progression of PD." @default.
• W2078347978 created "2016-06-24" @default.
• W2078347978 creator A5019768448 @default.
• W2078347978 creator A5020711878 @default.
• W2078347978 creator A5028444221 @default.
• W2078347978 creator A5030279598 @default.
• W2078347978 creator A5032562648 @default.
• W2078347978 creator A5033169343 @default.
• W2078347978 creator A5039947785 @default.
• W2078347978 creator A5044301848 @default.
• W2078347978 creator A5051756613 @default.
• W2078347978 creator A5054451714 @default.
• W2078347978 creator A5080477732 @default.
• W2078347978 date "2015-02-06" @default.
• W2078347978 modified "2023-10-18" @default.
• W2078347978 title "Anti-Human α-Synuclein N-Terminal Peptide Antibody Protects against Dopaminergic Cell Death and Ameliorates Behavioral Deficits in an AAV-α-Synuclein Rat Model of Parkinson’s Disease" @default.
• W2078347978 cites W1558808632 @default.
• W2078347978 cites W1635181960 @default.
• W2078347978 cites W1786559844 @default.
• W2078347978 cites W1966788000 @default.
• W2078347978 cites W1967640115 @default.
• W2078347978 cites W1970864084 @default.
• W2078347978 cites W1973114784 @default.
• W2078347978 cites W1974156328 @default.
• W2078347978 cites W1975638928 @default.
• W2078347978 cites W1977376243 @default.
• W2078347978 cites W1979591162 @default.
• W2078347978 cites W1991993391 @default.
• W2078347978 cites W2001408101 @default.
• W2078347978 cites W2003181166 @default.
• W2078347978 cites W2013313629 @default.
• W2078347978 cites W2014102001 @default.
• W2078347978 cites W2016639408 @default.
• W2078347978 cites W2018481846 @default.
• W2078347978 cites W2021267750 @default.
• W2078347978 cites W2023247637 @default.
• W2078347978 cites W2025810715 @default.
• W2078347978 cites W2026455995 @default.
• W2078347978 cites W2028383367 @default.
• W2078347978 cites W2029319167 @default.
• W2078347978 cites W2037692380 @default.
• W2078347978 cites W2038636807 @default.
• W2078347978 cites W2039334290 @default.
• W2078347978 cites W2043635206 @default.
• W2078347978 cites W2053858663 @default.
• W2078347978 cites W2055727403 @default.
• W2078347978 cites W2060851420 @default.
• W2078347978 cites W2069426573 @default.
• W2078347978 cites W2070772378 @default.
• W2078347978 cites W2077023014 @default.
• W2078347978 cites W2082429191 @default.
• W2078347978 cites W2083111107 @default.
• W2078347978 cites W2087853632 @default.
• W2078347978 cites W2095442135 @default.
• W2078347978 cites W2098069894 @default.
• W2078347978 cites W2113403926 @default.
• W2078347978 cites W2116456562 @default.
• W2078347978 cites W2116597539 @default.
• W2078347978 cites W2117503265 @default.
• W2078347978 cites W2118221606 @default.
• W2078347978 cites W2120001716 @default.
• W2078347978 cites W2139348656 @default.
• W2078347978 cites W2141627904 @default.
• W2078347978 cites W2144094733 @default.
• W2078347978 cites W2148034536 @default.
• W2078347978 cites W2150707747 @default.
• W2078347978 cites W2152446053 @default.
• W2078347978 cites W2155737332 @default.
• W2078347978 cites W2158652663 @default.
• W2078347978 cites W2159247740 @default.
• W2078347978 cites W2172296192 @default.
• W2078347978 cites W2318382508 @default.
• W2078347978 cites W4239908405 @default.
• W2078347978 doi "https://doi.org/10.1371/journal.pone.0116841" @default.
• W2078347978 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4319932" @default.
• W2078347978 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25658425" @default.
• W2078347978 hasPublicationYear "2015" @default.
• W2078347978 type Work @default.
• W2078347978 sameAs 2078347978 @default.
• W2078347978 citedByCount "70" @default.
• W2078347978 countsByYear W20783479782015 @default.
• W2078347978 countsByYear W20783479782016 @default.
• W2078347978 countsByYear W20783479782017 @default.
• W2078347978 countsByYear W20783479782018 @default.
• W2078347978 countsByYear W20783479782019 @default.
• W2078347978 countsByYear W20783479782020 @default.
• W2078347978 countsByYear W20783479782021 @default.
• W2078347978 countsByYear W20783479782022 @default.
• W2078347978 countsByYear W20783479782023 @default.
• W2078347978 crossrefType "journal-article" @default.
• W2078347978 hasAuthorship W2078347978A5019768448 @default.
• W2078347978 hasAuthorship W2078347978A5020711878 @default.
• W2078347978 hasAuthorship W2078347978A5028444221 @default.
• W2078347978 hasAuthorship W2078347978A5030279598 @default.
• W2078347978 hasAuthorship W2078347978A5032562648 @default.
• W2078347978 hasAuthorship W2078347978A5033169343 @default.
• W2078347978 hasAuthorship W2078347978A5039947785 @default.
• W2078347978 hasAuthorship W2078347978A5044301848 @default.

• next